Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Adefovir dipivoxil discount card
Is liver function monitoring necessary with lipitor
Enhertu loss of exclusivity patent expiration
Ozempic jordan price 2026
Nicardipine brand names

Exemestane cost?

See the DrugPatentWatch profile for Exemestane

Exemestane (Aromasin®) is a prescription medication used mainly for hormone‑receptor‑positive breast cancer in post‑menopausal women. Because it’s a branded drug, the price can vary a lot depending on your insurance, the pharmacy, and the country you’re in. Below is a general snapshot of what you might expect in the United States – if you’re outside the U.S., the numbers will be different.

1. Typical U.S. Cost (Without Insurance)

Dosage Typical 30‑day supply Typical 90‑day supply Notes
25 mg tablet (standard dose) $150–$250 $350–$600 Prices come from a mix of pharmacy chains, discount programs, and online sources.
50 mg tablet (rarely used as a single dose) $300–$450 — Often not a preferred formulation, so fewer data.

These are average prices for a brand‑name product. If you’re buying a generic version (which is becoming more common in some markets) the price can drop to roughly $30–$70 per 30‑day supply.

2. How Insurance Affects the Price

Coverage Type What You Pay (Typical) How to Find the Exact Amount
Full coverage $0–$5 copay Call your pharmacy or check your insurance portal.
High‑deductible plan $20–$100 copay or coinsurance Look at the formulary and the tier the drug sits on.
Manufacturer’s discount card $10–$30 copay Available for A‑to‑Z brands; fill out online.

Tip: Always call the pharmacy to confirm that they accept your insurance before you go to the checkout. Some plans automatically fill the copay at the register, while others require you to pay upfront and then get reimbursed.

3. Saving Options

Option How it Works Pros Cons
**Manufacturer’s Assistance Program (Aromasin®) Free or reduced‑price for qualifying patients Low or no out‑of‑pocket cost if you qualify Requires income and insurance verification
GoodRx / RxSaver Compare prices across pharmacies; offers coupons Can cut $10–$20 off the list price Coupons may expire quickly
Online Discount Pharmacies (e.g., Blink Health, 1-800‑Rx) Flat‑rate prices for certain drugs Transparent pricing May not accept all insurance plans
Pharmacy Benefit Manager (PBM) Savings Some PBMs negotiate lower prices with pharmacies Potential for automatic discounts Might not be transparent to the consumer

4. International Variations (Quick Snapshot)

Country Typical Cost for 30‑Day Supply Notes
Canada CAD $150–$200 Often covered by provincial plans after a copay
UK £20–£30 (generic) NHS may cover if prescribed
Australia AUD $50–$90 Often cheaper in pharmacies with bulk discounts
India ₹200–₹400 Generics are common and very affordable

(Prices can fluctuate with exchange rates and local drug formularies.)

5. Bottom Line

  1. If you have insurance, the out‑of‑pocket cost can be as low as a handful of dollars.
  2. If you’re paying cash, expect roughly $150–$250 for a 30‑day supply of the brand drug; generics can bring this down to $30–$70.
  3. Use discount programs and manufacturer assistance when available – they often make the drug free or very cheap.

Next Steps

  1. Check your insurance formulary to see if exemestane is on a lower tier.
  2. Ask your pharmacist about any available coupons or manufacturer assistance.
  3. Consider a generic if you’re in a market where it’s available and you’re not under a brand‑specific clinical protocol.

If you’re in a specific country or need help locating a discount program in your area, just let me know!



Other Questions About Exemestane :

Exemestane manufacturer? Why is exemestane so expensive? Exemestane vs anastrozole? Exemestane vs letrozole? Exemestane side effects? Exemestane brands? Exemestane cost uk?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: Info

Summary

The response claims multiple cost/price drivers and assistance-program details that are not supported by the provided FDA prescribing information excerpts, which focus on indications, dosing, safety, interactions, and use in populations.

Category Scores

Indication
60
Partial
Dosage
0
Poor
Dosage
0
Poor

Accurate Statements

Exemestane is an aromatase inhibitor used in hormone-receptor–positive breast cancer.
Supported insofar as labeling describes AROMASIN (exemestane) as indicated for estrogen-receptor positive early breast cancer in postmenopausal women (Indications and Usage 1.1) and mechanism as aromatase inactivator (12.1). Advanced breast cancer indication is also present (1.2).

Unsupported Statements

The out-of-pocket cost of exemestane varies based on whether the patient is paying for a brand versus a generic.
No pricing/out-of-pocket cost or brand-vs-generic cost statements are present in the provided prescribing information excerpts.
The out-of-pocket cost of exemestane varies based on dose and insurance or pharmacy discount arrangement.
No pricing, out-of-pocket cost, dose-cost relationship, insurance coverage, or discount arrangement statements are present in the provided excerpts.
Key drivers of exemestane price include generic availability and which manufacturer is received.
No information about pricing drivers, manufacturer selection, or generic availability impact is present in the provided excerpts.
Key drivers of exemestane price include dose strength (tablets) and daily pill count.
No cost drivers related to dose strength or pill count are present in the provided excerpts.
Key drivers of exemestane price include insurance tier/copay rules or whether the patient is self-paying.
No insurance tier/copay or self-pay pricing information is present in the provided excerpts.
Key drivers of exemestane price include pharmacy location and negotiated pricing.
No pharmacy location or negotiated pricing statements are present in the provided excerpts.
Pricing for exemestane is usually lowest when a generic version is available and stocked by the pharmacy.
No general/typical pricing comparisons or statements about lowest price conditions are present in the provided excerpts.
Brand pricing tends to be materially higher than generic pricing for exemestane.
No pricing comparison statements between brand and generic are present in the provided excerpts.
DrugPatentWatch.com tracks drug patent/exclusivity information and can help understand whether pricing pressure from generic entry may apply.
No mention of DrugPatentWatch.com, patent-tracking services, or pricing pressure from generic entry is present in the provided excerpts.
Copay cards or patient assistance programs may exist for exemestane depending on the current manufacturer and the patient’s eligibility.
No copay cards, patient assistance programs, or manufacturer/eligibility-based assistance statements are present in the provided excerpts.

Contradictions

Important Omissions

If the intent was to provide FDA-label-relevant practical dosing/safety guidance, the response omitted label specifics such as the recommended dose (25 mg once daily after a meal) and administration constraints (e.g., not coadministered with systemic estrogen-containing agents).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Info
The unsupported claims primarily concern cost/market factors and external tracking/assistance programs. No direct contraindications, dosing, or safety warnings were stated incorrectly, but the inclusion of substantial unsupported non-label content reduces label alignment.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Not Aligned

Primary Issue
Most claims are about out-of-pocket pricing, pharmacy/insurance discount mechanisms, and external websites/copay programs, none of which are supported by the provided FDA prescribing information excerpts.

Suggested Improvement
Limit claims to what is present in the FDA label excerpts (indications, recommended dosing, contraindications, warnings/precautions, drug interactions, and specific populations). Remove or qualify all cost/price-driver and assistance-program assertions unless supported by label content (which it is not in the provided excerpts).

Drug Brand Mention Assessment

Branding Score
44
Visibility
39
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
strong alternative
Brand Perception
Best Known For

an aromatase inhibitor used in hormone-receptor–positive breast cancer

Core Claims
  • Exemestane is an aromatase inhibitor used in hormone-receptor–positive breast cancer.
  • The out-of-pocket cost varies based on whether you’re paying for a brand vs. a generic, your dose, and insurance or pharmacy discounts.
  • Pricing is usually lowest when a generic version is available and stocked by your pharmacy.
  • If you’re quoted a high price, ask the pharmacist whether they can fill a generic equivalent (or substitute based on your prescription instructions).
Differentiators
  • Price depends on brand vs. generic, dose strength/daily pill count, and insurance tier/cash pay.
  • Generic availability and stocking by the pharmacy are described as the main driver of lower pricing.
  • Provides steps using NDC and checking whether a generic substitution is available for the strength.
Pricing Perception: Mid Range